These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
175 related items for PubMed ID: 19896319
21. Treatment of acute nonlymphocytic leukemia by combination of recombinant human granulocyte colony-stimulating factor and cytotoxic agents: a report of six cases. Hanazono Y, Miyazono K, Piao YF, Taketazu F, Chiba S, Miyagawa K, Hirai H, Sakamoto S, Miura Y, Yazaki Y. Int J Hematol; 1992 Jun; 55(3):243-8. PubMed ID: 1379844 [Abstract] [Full Text] [Related]
22. Scopulariopsis brevicaulis infection in a patient with acute myeloid leukemia. Ng KP, Soo-Hoo TS, Na SL, Gan GG, Sangkar JV, Teh AK. Med J Malaysia; 2003 Oct; 58(4):608-12. PubMed ID: 15190640 [Abstract] [Full Text] [Related]
23. Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of relapsed or poor risk childhood acute leukemia. Yalman N, Sarper N, Devecioğlu O, Anak S, Eryilmaz E, Can M, Yenilmez H, Ağaoğlu L, Gedikoğlu G. Turk J Pediatr; 2000 Oct; 42(3):198-204. PubMed ID: 11105617 [Abstract] [Full Text] [Related]
25. Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation. You Y, Li QB, Chen ZC, Li WM, Xia LH, Zhou H, Zou P. Chin Med J (Engl); 2008 Sep 20; 121(18):1770-4. PubMed ID: 19080355 [Abstract] [Full Text] [Related]
26. FLAG-IDA in the treatment of refractory/relapsed acute myeloid leukemia: single-center experience. Pastore D, Specchia G, Carluccio P, Liso A, Mestice A, Rizzi R, Greco G, Buquicchio C, Liso V. Ann Hematol; 2003 Apr 20; 82(4):231-5. PubMed ID: 12707726 [Abstract] [Full Text] [Related]
27. AmBisome treatment of fungal sinusitis in severe immunocompromised patient with acute lymphoblastic leukemia relapsed after autologous peripheral blood transplantation. Rokicka M. Acta Biomed; 2006 Apr 20; 77 Suppl 2():26-7. PubMed ID: 16918064 [Abstract] [Full Text] [Related]
29. Utility of molecular identification in opportunistic mycotic infections: a case of cutaneous Alternaria infectoria infection in a cardiac transplant recipient. Lo Cascio G, Ligozzi M, Maccacaro L, Fontana R. J Clin Microbiol; 2004 Nov 20; 42(11):5334-6. PubMed ID: 15528736 [Abstract] [Full Text] [Related]
30. Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor for elderly patients with previously untreated acute myeloid leukemia. Suzushima H, Wada N, Yamasaki H, Eto K, Shimomura T, Kugimiya MH, Horikawa K, Nishimura S, Tsuda H, Mitsuya H, Asou N. Leuk Res; 2010 May 20; 34(5):610-4. PubMed ID: 19744710 [Abstract] [Full Text] [Related]
33. A suspected squamous cell carcinoma in a renal transplant recipient revealing a rare cutaneous phaeohyphomycosis by Alternaria infectoria. Tambasco D, D'Ettorre M, Bracaglia R, Massi G, Posteraro B, Torelli R, De Simone C, Capizzi R. J Cutan Med Surg; 2012 May 20; 16(2):131-4. PubMed ID: 22513067 [Abstract] [Full Text] [Related]
34. Invasive fungal infections in patients with acute myeloid leukemia and in those submitted to allogeneic hemopoietic stem cell transplant: who is at highest risk? Caira M, Girmenia C, Fadda RM, Mitra ME, Picardi M, Van Lint MT, Nosari A, Candoni A, Bonini A, Mattei D, de Waure C, Fianchi L, Valentini CG, Aversa F, Leone G, Pagano L. Eur J Haematol; 2008 Sep 20; 81(3):242-3. PubMed ID: 18485113 [No Abstract] [Full Text] [Related]
35. Invasive fungal rhinosinusitis in Maharaj Nakorn Chiang Mai Hospital. Roongrotwattanasiri K, Fooanant S, Naksane L. J Med Assoc Thai; 2007 Nov 20; 90(11):2524-8. PubMed ID: 18181345 [Abstract] [Full Text] [Related]
38. Invasive phaeohyphomycosis co-infection with Alternaria spp. and Curvularia spp. in a neutropenic host. Sikora A, Johnson J, Velez A, Greene J. J Mycol Med; 2024 Sep 20; 34(3):101497. PubMed ID: 38991295 [Abstract] [Full Text] [Related]
39. Combination chemotherapy with low-dose cytarabine, homoharringtonine, and granulocyte colony-stimulating factor priming in patients with relapsed or refractory acute myeloid leukemia. Zhang WG, Wang FX, Chen YX, Cao XM, He AL, Liu J, Ma XR, Zhao WH, Liu SH, Wang JL. Am J Hematol; 2008 Mar 20; 83(3):185-8. PubMed ID: 17899614 [Abstract] [Full Text] [Related]